Liminatus Pharma reported total assets of $3.40M and total liabilities of $3.10M for the quarter ended Jun 2026, up 78.3% year over year. This balance sheet covers 9 quarters of results from Jun 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Current Assets | |||||||||
| Cash & EquivalentsCash & Equiv. | 0.03M | 0.05M | 0.06M | 0.03M | 1.34M | 0.72M | 0.34M | 1.91M | 3.02M |
| Receivables - OtherOther Receivables | 0.13M | 0.13M | 0.13M | ||||||
| Prepaid Assets | 0.16M | 0.44M | 0.48M | 0.16M | 0.87M | 0.38M | |||
| Current Assets | 5.28M | 1.78M | 1.20M | 0.50M | 2.78M | 3.39M | |||
| Non-Current Assets | |||||||||
| Property, Plant & Equipment (Net) | 941.00 | 198.00 | 0.01M | 0.01M | 0.01M | 0.01M | |||
| Non-Current Assets | 0.13M | 0.13M | 0.14M | 0.01M | 0.01M | 0.01M | |||
| Assets | 5.41M | 1.91M | 1.34M | 0.51M | 2.79M | 3.40M | |||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts Payables | 1.48M | 0.43M | 0.56M | 0.58M | 0.53M | 0.66M | |||
| Notes Payables | 2.80M | 2.80M | 19.97M | 0.21M | 1.44M | 1.44M | 1.44M | 1.44M | 1.44M |
| Payables | 2.80M | 2.80M | 21.46M | 0.21M | 1.87M | 2.00M | 2.02M | 1.97M | 2.10M |
| Accumulated Expenses | 805.00 | 0.00M | |||||||
| Other Accumulated Expenses | 1.98M | 0.17M | 0.18M | 0.21M | 0.19M | 0.20M | |||
| Total Current Liabilities | 24.75M | 10.52M | 2.86M | 10.30M | 2.89M | 3.04M | |||
| Non-Current Liabilities | |||||||||
| Other Non-Current Liabilities | 0.20M | 0.12M | 0.03M | 0.03M | 0.06M | ||||
| Total Non-Current Liabilities | 10.52M | 2.86M | 10.30M | 2.89M | 3.04M | ||||
| Total Liabilities | 24.75M | 10.72M | 2.99M | 10.33M | 2.92M | 3.10M | |||
| Shareholder's Equity | |||||||||
| Total Debt | 2.80M | 2.80M | 19.97M | 0.21M | 1.44M | 1.44M | 1.44M | 1.44M | 1.44M |
| Common Equity | -18.51M | -19.11M | -19.34M | -19.67M | -8.81M | -1.65M | -9.81M | -0.13M | 0.30M |
| Liabilities and Shareholders Equity | 5.41M | 1.91M | 1.34M | 0.51M | 2.79M | 3.40M | |||
| Retained Earnings | -28.67M | -0.00M | -28.88M | -30.70M | -38.87M | -40.00M | -41.40M |
Pull Liminatus Pharma's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=LIMN&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "LIMN", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=LIMN&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();